Royal Bank of Canada’s St Jude Medical STJ Stock Holding History

Royal Bank of Canada’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-45,200	Closed	-$2.49M	–	6706
2016 Q1	$2.49M	Buy	+45,200	New	+$2.46M	﹤0.01%	2295
2015 Q4	–	Sell	-35,500	Closed	-$2.24M	–	7053
2015 Q3	$2.24M	Buy	+35,500	New	+$2.53M	﹤0.01%	2181

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Royal Bank of Canada's STJ Position: Q1 2017 in Review

Royal Bank of Canada sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 63,142 shares — an estimated $5.06M sold.

Royal Bank of Canada first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $68.3M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Royal Bank of Canada reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Royal Bank of Canada sold 63,142 St Jude Medical shares in Q1 2017, an estimated $5.06M.
Royal Bank of Canada first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
Royal Bank of Canada's St Jude Medical position peaked at $68.3M in Q2 2014.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Royal Bank of Canada's 13F filing for Q1 2017, filed 15 May 2017.